Masayo Takahashi

Project Leader, Retinal Regeneration



Biomedical Sciences

Takahashi has been recognized for her trailblazing work with the inaugural Ogawa-Yamanaka Stem Cell Prize 2015. She led the world’s first clinical trial to use induced pluripotent stem cells in humans, with the intent to treat retinal diseases.

(Photo: Masayo Takahashi/RIKEN)

  • Ogawa-Yamanaka Stem Cell Prize 2015

Related articles

Celebrating Excellence in Asia With The Asian Scientist 100

These rising stars and veterans hail from diverse sectors in industry and academia, but they all share in one common mission—to make tomorrow a better place for you and me.

7 Inspiring Scientists Who Happen To Be Women

These seven women have all overcome the odds to become leaders in their own fields.

Stem Cell Transplant Restores Vision In Mice

Retinal transplants grown from induced pluripotent stem cells can restore vision in mice, study shows.

The Ups And Downs Of Hibernation-Like Daily Torpor

The key to the state of daily torpor, researchers have found, is reduced sensitivity to the fall of body temperature.

12 Scientists From Japan To Watch

By no means an exhaustive list, these 12 scientists have made significant contributions to Japan's science and technology landscape.

The Women Of The Asian Scientist 100 (VIDEO)

From the co-discoverer of carbon nanotubes to the first Chinese woman to win a Nobel Prize, here are the 15 female scientists featured on the AS100 list.

Bringing Sight To The Blind

Professor Masayo Takahashi, who performed the world's first induced pluripotent stem cell-derived transplant into humans, has a vision for stem cells in the clinic.

First iPSC Transplant Patient Doing Well

The first patient to receive an iPS cell transplant has shown no tumor formation since her surgery in 2014.

Editor’s Note – April 2015 Print Magazine

Check out our exclusive interviews with Takeda's Dr. Tachi Yamada and RIKEN's Professor Masayo Takahashi in the April 2015 print magazine!